DaVita paid $450 million over unnecessary dialysis drug waste billed to government programs
Company: DaVita Inc.
Summary
DaVita paid $450 million to resolve allegations that it knowingly created unnecessary waste when administering dialysis drugs Zemplar and Venofer and then billed federal healthcare programs for the avoidable waste. Source: https://www.justice.gov/archives/opa/pr/justice-department-recovers-over-35-billion-false-claims-act-cases-fiscal-year-2015